Check Out What’s New at Goldfinch

04.20.21

Goldfinch Bio Expands Board of Directors with Appointments of Meryl Zausner, Hon. William “Mo” Cowan and Tyrell Rivers, Ph.D.

11.19.20

Goldfinch Bio Announces Appointment of Robin A. Walker, J.D., as Chief Legal Officer

10.22.20

Goldfinch Bio Presents Clinical Data from Phase 1 Trial Supporting Advancement of GFB-887 as a Precision Medicine for Patients with Kidney Diseases

10.14.20

Goldfinch Bio Honored by Goldman Sachs for Entrepreneurship

10.13.20

Goldfinch Bio Announces Upcoming Presentation of Phase 1 Clinical Data for Lead Precision Kidney Therapeutic Candidate, GFB-887, and Expansion of Scientific Leadership Team